Schedule

The ACCP Updates in Therapeutics®: Pharmacotherapy Preparatory Review and Recertification Course will be held Saturday and Sunday, April 27-28, 2019.

Click below for the full meeting schedule.

Updates in Therapeutics® 2019 Preparatory
Review and Recertification Courses
April 27-28, 2019


Pharmacotherapy Preparatory Review and Recertification Course -- Audio Recorded Topics - Fluids, Electrolytes and Nutrition, Pharmacokinetics, and Gastrointestinal Disorders

Monday, April 29, 2019

Available for 4.00 hours of CPE credit
Activity Number: 0217-0000-19-085-H01-P

The following topics will be recorded and made available to participants of the course by July 1, 2019. These recorded topics are included in your meeting registration at no additional charge.





Pharmacotherapy Preparatory Review and Recertification Course – Fluids, Electrolytes and Nutrition, Pharmacokinetics, and Gastrointestinal Disorders

Activity No. 0217-0000-19-085-H01-P; 4.0 contact hours; Application-based activity



Gastrointestinal Disorders

Speakers
Faculty: Sheila M. Wilhelm, Pharm.D., FCCP, BCPS
Clinical Associate Professor, Wayne State University, Detroit, Michigan
View Biography
Sheila M. Wilhelm, Pharm.D., FCCP, BCPS
Wilhelm

Learning Objectives
1. Review national guideline treatment strategies for the following gastrointestinal (GI) disorders: gastroesophageal reflux disease (GERD); peptic ulcer disease (PUD); ulcerative colitis (UC); Crohn disease (CD); chronic liver disease, including viral hepatitis and cirrhosis; constipation; diarrhea; irritable bowel syndrome (IBS); nausea; vomiting; pancreatitis; and upper GI bleeding, including prevention of stress-related mucosal disease (SRMD).
2. Recommend appropriate pharmacologic and nonpharmacologic interventions given a specific patient with one or more GI disorders.
3. Recognize pertinent information for educating patients and prescribers regarding the appropriate use of pharmacologic agents for various GI disorders.
4. Describe commonly encountered statistical tests and concepts, using GI disorders as examples.
Pharmacokinetics

Speakers
Faculty: Curtis L. Smith, Pharm.D., BCPS
Professor, Ferris State University, Lansing, Michigan
View Biography
Curtis L. Smith, Pharm.D., BCPS
Smith

Learning Objectives
1. Identify and solve pharmacotherapy problems using basic pharmacokinetic concepts, including bioavailability, volume of distribution, clearance, and the elimination rate constant.
2. Describe clinically relevant issues related to drug transport proteins, cytochrome P450 metabolism, pharmacogenomics, and drug sampling and interpretation.
3. Describe specific pharmacokinetic characteristics of commonly used therapeutic agents, including aminoglycosides, vancomycin, phenytoin, and digoxin, as well as pharmacokinetic alterations in patients with renal and hepatic disease.
Fluids, Electrolytes, and Nutrition

Speakers
Facilitator: Leslie A. Hamilton, PharmD, FCCP, BCPS, BCCCP
Associate Professor, Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center, College of Pharmacy, Knoxville, Tennessee
View Biography
Leslie A. Hamilton, PharmD, FCCP, BCPS, BCCCP
Hamilton

Learning Objectives
1. Calculate the osmolarity of intravenous fluids and compare each with normal plasma osmolarity.
2. Recommend an appropriate intravenous fluid regimen and monitoring parameters given a patient clinical scenario.
3. Discuss the appropriate roles and risks of hypertonic and hypotonic saline, recommend treatment regimens, and discuss appropriate monitoring parameters to ensure safe and effective use of these intravenous fluids.
4. Assess electrolyte abnormalities and recommend an appropriate pharmacologic treatment plan based on individual patient signs and symptoms.
5. Discuss appropriate indications for the use of enteral nutrition (EN) and parenteral nutrition (PN).
6. Recommend a patient-specific EN formula, infusion rate, and monitoring parameters based on nutritional needs, comorbidities, and clinical condition.
7. Recommend a patient-specific PN formula and monitoring plan based on the type of intravenous access, nutritional needs, comorbidities, and clinical condition.
8. Discuss strategies for preventing complications associated with EN and PN.